home about sciencentral contact
sciencentral news: making sense of science
life sciences physi cal sciences technology full archive
astronomychemistryearthmaterialsphysicsclimateoceans
February 9, 2010
ScienCentral

Lifesaving Sponges?


Post/Bookmark this story:

Search (Archive Only)
 

Cancer Prognosis - Breast cancer tumors have genetic signatures that could tell doctors how to treat them, and erase a lot of guesswork. (5/20/03)

Drugs from the Deep - Ocean scientists have found an unlikely new source of many drugs— deep ocean mud. (4/29/03)

 

Partners in Research: Use of Animals – Marine Sponge

Was the Humble Sponge Earth's First Animal?



   12.02.03
email to a friend
 
 
play video Video
Sponge on ocean bottom
image: Harbor Branch Oceanographic Institution
(movie will open in a separate window)
Choose your format:
Quicktime
Realmedia

You wash dishes, clean the floor, and wash your car with sponges that you buy from the store. But as this ScienCentral News video reports, sponges from the sea could be a source of new drugs.

Sponge Pharmacy

When asked what she likes about sponges, Amy Wright, director of the division of biomedical marine research at Harbor Branch Oceanographic Institution, replies, "They don't move. They're easy to catch, and they have lots of great chemistry."

Sponges are animals that attach to the ocean bottom. Because they can't escape from predators or scavengers, sponges have had to develop special defenses. Fortunately, some of those defenses may be useful as medicines for us.

"[Sponges] can't run away from predators," Shirley Pomponi, vice president and director of research at Harbor Branch Oceanographic Institution, explains. "They can't move away from things that are trying to grow over top of them. So if you imagine yourself being a sponge and there's something else that's trying to grow over top of you, how do you defend yourself? And one way you might defend yourself is to make a chemical that prevents the cells from that other organism from dividing. And that's what a lot of anti-cancer drugs do— they prevent those cancer cells from dividing."





Johnson Sea Link submarine
image: Harbor Branch Oceanographic Institution
Pomponi and Wright use submarines to collect sponges from the bottom of the ocean. Then they put each species of sponge into a blender and add alcohol to make what Pomponi calls a "sponge daiquiri." The chemicals from the sponge are drawn, or "extracted" into the alcohol. Each extract contains dozens or even hundreds of chemicals. They use a test called "bioassay guided identification" to find out whether there are any chemicals in the extract that could be used as medicines. "So if we want to see if we can kill cancer cells, we'll treat cancer cells with the extract and look to see that they don't grow or divide," Wright explains. If the extract passes the test, then they use chemical techniques to repeatedly separate some of the chemicals from others. They test each new solution until eventually they find the one chemical from the extract that has the desired effect.

"You can find lots of different chemical compounds that have lots of different utilities," Wright says. "We have ones that have what look like anti-cancer properties; we have ones with anti-inflammatory activities, so those might be useful in things like arthritis, or dermatological use; we have ones that are anti-infective, so they're antibacterial and there are some that might actually be useful in treating viral diseases as well."





Even after they purify each chemical, the researchers still have a lot more to do, including identifying the chemical's structure and how it works, and testing to see how effective or toxic it may be. They test it first on lab cultures of living cells. "We'll do things to determine if they're toxic to all cells," says Pomponi. "If they're toxic to all cells, then that's probably not going to be something that we'll want to develop, because obviously you don't want to take a drug that's going to kill all of the cells in your body. You just want something that's going to focus on the cancer cells." After that, they test it in animals, and eventually, they patent it and license it out to a drug company for further development and ultimately human testing.




Several of the chemicals they've found are already being tested on humans, but it may be years before each is determined safe. One of the most promising is called discodermolide from the sponge Discodermia. Pharmaceutical company Novartis is conducting a clinical trial of this anti-cancer drug in patients with colon and breast cancer.

Runaway Sponge

While sponges can't run away, one did "disappear" for nearly two decades. In 1984, Pomponi and Wright found a sponge that turned out to have an extremely promising anti-cancer agent. Unfortunately, they had not collected enough of this particular type of sponge to identify the chemical's structure, and when they went back to get more sponge, they couldn't find it again. Luckily, after 19 years of hoping and after carefully identifying the conditions in which this sponge likes to live, they recently found the "missing" sponge again. They plan to finish their analyses of its promising chemical and to get it into human trials as soon as possible.

How important is the ocean in all of this? "I've heard the statistic that about half of the drugs out there today are derived from or based on natural products that came from terrestrial plants or microbes," says Pomponi. "Even though we've done work for about 20 years on marine natural products drug discovery, we really have focused just on a few areas of our world's oceans. There's so much left to explore. For example, marine microorganisms: It's estimated that we know maybe less than a tenth of a percent of all the marine microorganisms that exist and that would be an invaluable resource for drug discovery. We know so little about the oceans, and the oceans have a huge impact on many aspects of our lives— on our climate, on our health, on food, on so many things that affect us."

Pomponi and Wright's research has been published in the December, 2003 issue of the Journal of Natural Products, the October, 2003 issue of Marine Biotechnology, the May, 2003 issue of Bioorganic & Medicinal Chemistry Letters, the February, 2003 issue of Biochemical Pharmacology, among others. It was recently presented at the Oceans 2003 Marine Technology and Ocean Science Conference in San Diego. It was funded by the Harbor Branch Oceanographic Institution, the Gertrude E. Skelly Charitable Foundation, NOAA's Office of Ocean Exploration, the National Science Foundation, the National Institutes of Health, the National Cancer Institute (Part of NIH), the Atlantic Foundation, Novartis Institutes for Biomedical Research and the NOAA Sea Grant College Program.


 
       email to a friend by Donna Vaughan
               
     


Science Videos     Terms of Use     Privacy Policy     Site Map      Contact      About
 
ScienCentral News is a production of ScienCentral, Inc. in collaboration with The Center for Science and the Media 248 West 35th St., 17th Fl., NY, NY 10001 USA (212) 244-9577. The contents of these WWW sites © ScienCentral, 2000-2010. All rights reserved. This material is based on work supported by the National Science Foundation under Grant No. ESI-0206184. The views expressed in this website are not necessarily those of The National Science Foundation or any of our other sponsors. Image Credits National Science Foundation